Content area

Abstract

Summary

Complicated community-acquired pneumonia in a previously well child is a severe illness characterised by combinations of local complications (eg, parapneumonic effusion, empyema, necrotising pneumonia, and lung abscess) and systemic complications (eg, bacteraemia, metastatic infection, multiorgan failure, acute respiratory distress syndrome, disseminated intravascular coagulation, and, rarely, death). Complicated community-acquired pneumonia should be suspected in any child with pneumonia not responding to appropriate antibiotic treatment within 48–72 h. Common causative organisms are Streptococcus pneumoniae and Staphylococcus aureus. Patients have initial imaging with chest radiography and ultrasound, which can also be used to assess the lung parenchyma, to identify pleural fluid; CT scanning is not usually indicated. Complicated pneumonia is treated with a prolonged course of intravenous antibiotics, and then oral antibiotics. The initial choice of antibiotic is guided by local microbiological knowledge and by subsequent positive cultures and molecular testing, including on pleural fluid if a drainage procedure is done. Information from pleural space imaging and drainage should guide the decision on whether to administer intrapleural fibrinolytics. Most patients are treated by drainage and more extensive surgery is rarely needed; in any event, in low-income and middle-income countries, resources for extensive surgeries are scarce. The clinical course of complicated community-acquired pneumonia can be prolonged, especially when patients have necrotising pneumonia, but complete recovery is the usual outcome.

Details

Title
Complicated pneumonia in children
Author
de Benedictis, Fernando M 1 ; Kerem, Eitan 2 ; Chang, Anne B 3 ; Colin, Andrew A 4 ; Zar, Heather J 5 ; Bush, Andrew 6 

 Salesi Children's Hospital Foundation, Ancona, Italy 
 Department of Pediatrics, Hadassah Hebrew University Hospital, Jerusalem, Israel 
 Child Health Division, Menzies School of Health Research, Darwin, NT, Australia; Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, South Brisbane, QLD, Australia; Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, QLD, Australia 
 Division of Pediatric Pulmonology, Miller School of Medicine, University of Miami, Miami, FL, USA 
 Department of Paediatrics and Child Health, Red Cross Children's Hospital, Cape Town, South Africa; MRC Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa 
 Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial School of Medicine, Imperial College London, London, UK 
Pages
786-798
Section
Review
Publication year
2020
Publication date
Sep 12, 2020
Publisher
Elsevier Limited
ISSN
01406736
e-ISSN
1474547X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2441542030
Copyright
©2020. Elsevier Ltd